Endoscopic revision of sleeve gastrectomy for reflux or poor weight loss
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests a new, less invasive way to convert a sleeve gastrectomy into a different type of weight-loss surgery (SASI) in people who have ongoing gastroesophageal reflux or haven't lost enough weight. The goal is to see if this endoscopic procedure can improve reflux and help with weight loss without the need for a traditional surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old.
- You have had a sleeve gastrectomy (weight-loss surgery) and are now experiencing reflux or haven't lost enough weight.
- You are willing to undergo a follow-up procedure to revise your existing surgery.
- You are not pregnant or breastfeeding.
- You do not have serious heart, kidney, or bleeding problems, or an active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a modified version of sleeve gastrectomy that aims to reduce the risk of acid reflux (GERD) after surgery. It is for people aged 18–65 with a BMI between 35 and 55 who already have some degree of GERD and are planning to have weight loss surgery.
This trial studies how sleeve gastrectomy affects metabolism, digestion, and weight loss in people with severe obesity. You are eligible if you recently had surgery and are not using certain supplements.
This trial studies a second surgery for people who have already had a weight-loss operation called a sleeve gastrectomy. The new surgery aims to improve weight loss and health by changing how food moves through the intestines.
This study compares two weight-loss surgeries for people who have both obesity and severe heartburn or GERD. One surgery combines part of the stomach removal with an anti-reflux wrap, while the other reroutes the stomach to help with weight loss and reflux.
This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.
This trial studies an endoscopic procedure to treat gastroesophageal reflux disease (GERD) in people who had gastric sleeve surgery. It may help if reflux symptoms are not controlled on once-daily acid medicine (PPI) or if you cannot tolerate it and want an alternative.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.